U.S. flag

An official website of the United States government

GRCh38/hg38 17q21.31-21.32(chr17:46444520-46990403)x3 AND See cases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 12, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000053135.5

Allele description [Variation Report for GRCh38/hg38 17q21.31-21.32(chr17:46444520-46990403)x3]

GRCh38/hg38 17q21.31-21.32(chr17:46444520-46990403)x3

Genes:
  • ARL17A:ADP ribosylation factor like GTPase 17A [Gene - HGNC]
  • LOC130061031:ATAC-STARR-seq lymphoblastoid silent region 8620 [Gene]
  • LOC126862578:BRD4-independent group 4 enhancer GRCh37_chr17:45008344-45009543 [Gene]
  • GOSR2-DT:GOSR2 divergent transcript [Gene - HGNC]
  • NSF:N-ethylmaleimide sensitive factor, vesicle fusing ATPase [Gene - OMIM - HGNC]
  • LOC121587598:Sharpr-MPRA regulatory region 11668 [Gene]
  • LOC112533644:Sharpr-MPRA regulatory region 12503 [Gene]
  • LOC121852935:Sharpr-MPRA regulatory region 3126 [Gene]
  • LOC125177492:Sharpr-MPRA regulatory region 3811 [Gene]
  • WNT3:Wnt family member 3 [Gene - OMIM - HGNC]
  • WNT9B:Wnt family member 9B [Gene - OMIM - HGNC]
  • LOC111589213:ZFP161 motif-containing MPRA enhancer 249 [Gene]
  • FAM215B:family with sequence similarity 215 member B [Gene - HGNC]
  • GOSR2:golgi SNAP receptor complex member 2 [Gene - OMIM - HGNC]
  • LINC01974:long intergenic non-protein coding RNA 1974 [Gene - HGNC]
  • MIR5089:microRNA 5089 [Gene - HGNC]
  • RPRML:reprimo like [Gene - HGNC]
  • LRRC37A2:leucine rich repeat containing 37 member A2 [Gene - OMIM - HGNC]
Variant type:
copy number gain
Cytogenetic location:
17q21.31-21.32
Genomic location:
Preferred name:
GRCh38/hg38 17q21.31-21.32(chr17:46444520-46990403)x3
HGVS:
  • NC_000017.11:g.(?_46444520)_(46990403_?)dup
  • NC_000017.10:g.(?_44485771)_(45067769_?)dup
  • NC_000017.9:g.(?_41841187)_(42422768_?)dup
Links:
dbVar: nssv580264; dbVar: nsv531823
Observations:
1

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000080491ISCA site 14

See additional submitters

criteria provided, single submitter

(Kaminsky et al. (Genet Med. 2011))
Uncertain significance
(Aug 12, 2011)
de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.

Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, et al.

Genet Med. 2011 Sep;13(9):777-84. doi: 10.1097/GIM.0b013e31822c79f9.

PubMed [citation]
PMID:
21844811
PMCID:
PMC3661946

Details of each submission

From ISCA site 14, SCV000080491.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: May 7, 2024